Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 2 of 4 | Showing Results 6 - 10 of 17

Natural History Study of the Development of Type 1 Diabetes.

(1) First degree relatives (age 1 – 45 years) of T1D probands. (2) Second and third degree relatives (age 1 – 20 years) of T1D probands: nieces,...

Steven Kunkel, M.D.
  • Kadlec Diabetes Learning Center
  • Kadlec Research

A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of anamorelin HCl for the treatment of malignancy associated weight loss and anorexia in adult patients with advanced non-small cell lung cancer (NSCLC)

Inclusion Criteria:1.Signed written informed consent2.Female or male ≥18 years of age3.Documented histologic or cytologic diagnosis of American...

Ying Zhuo, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research

Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

This is an open-label, multiple part, multicenter, phase 2 clinical trial. Part A will assess the incidence of febrile neutropenia, efficacy, and...

Rangaswamy Chintapatla, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research

Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab.

Inclusion Criteria:Able to understand the purpose and risk of the study and provide signed informed consent document.Must have received 12 or more...

Hui-Juan Zhang, M.D.
  • Kadlec Neuroscience Center
  • Kadlec Research

445BASTX727-06: An Open-Label, Multicenter, Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Inclusion Criteria:Subjects must fulfill all of the following inclusion criteria:Previous participation in an Astex-sponsored ASTX727 clinical...

Rangaswamy Chintapatla, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research
Viewing Page 2 of 4 | Showing Results 6 - 10 of 17